Technology | October 30, 2013

Terumo Interventional Systems Expands Line of Glidewire Advantage Peripheral Guidewires

New 0.0180-inch wire reduces need for multiple wire exchanges

Terumo cath lab guidewires glidewire advantage 0.0180 peripheral

October 30, 2013 — Terumo Interventional Systems announced the launch of the 0.018-inch Glidewire Advantage peripheral guidewire during the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.

The guidewire is intended to enable physicians to confidently cross the lesion, deliver the interventional device and maintain access throughout the procedure using a single wire. With the addition of a new size, the Glidewire Advantage line of specialty guidewires can now be used in a broader range of procedures, including visceral, above-the-knee and below-the-knee applications.

Terumo employs its proprietary DuoCore technology that fuses the original hydrophilic-coated Glidewire construction with a stiffer nitinol core encapsulated by a spiral, polytetrafluoroethylene (PTFE) coating. This design eliminates the need for multiple wire exchanges, which may reduce the risk of patient complications.

For more information: www.terumois.com

Related Content

Edwards Lifesciences Recalls Swan-Ganz hemodynamic catheters.
Feature | Cath Lab | February 06, 2019
Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufa
Scientists Discover New Heart Attack Repair Pathway

A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.

News | Cath Lab | January 30, 2019
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack....
Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
National Academy of Engineering, Ohio University Award 2019 Russ Prize
News | Cath Lab | January 03, 2019
Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be...
Videos | Cath Lab | January 03, 2019
This is a walk through inside one of the cardiac hybrid cath labs at the...
Videos | Cath Lab | January 03, 2019
This is the newest cardiac cath lab at the ...
Study Finds Effective Treatment for Coronary Slow Flow
News | Cath Lab | December 27, 2018
Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if...
Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Overlay Init